Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.8 (2025) • CiteScore: 4.2 (2025) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
Long-term economic benefits of early cancer detection through enhanced multimodal screening: a modeling study of whole-body MRI and liquid biopsy
Barbaros S Erdal
,
Ryoko Sato
,
Kim H McVeigh
,
Eduardo N Chini
,
Erik H Middlebrooks
,
Candice Bolan
,
Pamila Brar
,
Naomi Sazama
, and
David Karow
Journal of Comparative Effectiveness Research
11 Nov 2026
Efficacy and safety of sepiapterin versus sapropterin in people living with phenylketonuria: a plain language summary of the AMPLIPHY trial
Maria Giżewska
,
Laura Guilder
,
Sarah Gallagher
, and
Anita Inwood
Journal of Comparative Effectiveness Research
11 Nov 2026
ISPE updates RWE position statement with priorities for methods, AI and patient engagement
The Evidence Base
12 Nov 2026
UK’s MHRA publishes four-year plan for patient and public involvement in medicines and medical device regulation
The Evidence Base
12 Nov 2026
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
12 Nov 2026
ISPE updates RWE position statement with priorities for methods, AI and patient engagement
11 Nov 2026
ISPOR Europe 2026 daily round-ups: Insights from Day 3
11 Nov 2026
ISPOR Europe 2026 – Inside the third plenary: Evidence that changes decisions
11 Nov 2026
ISPOR Europe 2026 daily round-ups: Insights from Day 3
11 Nov 2026
ISPOR Europe 2026 – Inside the third plenary: Evidence that changes decisions
11 Nov 2026
MHRA and NICE invite proposals for RWE scientific dialogue
10 Nov 2026
ISPOR Europe 2026 daily round-ups: Insights from Day 2
9 Nov 2026
ISPOR Europe 2026 – Inside the first plenary: Beyond proving value – rethinking disease and redesigning healthcare
9 Nov 2026
ISPOR Europe 2026 daily round-ups: Insights from Day 1
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
12 Nov 2026
ISPE updates RWE position statement with priorities for methods, AI and patient engagement
12 Nov 2026
UK’s MHRA publishes four-year plan for patient and public involvement in medicines and medical device regulation
11 Nov 2026
ISPOR Europe 2026 daily round-ups: Insights from Day 3
11 Nov 2026
ISPOR Europe 2026 – Inside the third plenary: Evidence that changes decisions
.png)
.png)
